CK2 Activity Mediates the Aggressive Molecular Signature of Glioblastoma Multiforme by Inducing Nerve/Glial Antigen (NG)2 Expression

SIMPLE SUMMARY: Glioblastoma multiforme (GBM) is the most common and lethal primary malignant cancer of the central nervous system with a median patient survival of ~15 months. It has been reported that particularly nerve/glial antigen (NG)2-positive GBM is associated with an aggressive clinical phe...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, Beate M., Boewe, Anne S., Götz, Claudia, Philipp, Stephan E., Urbschat, Steffi, Oertel, Joachim, Menger, Michael D., Laschke, Matthias W., Ampofo, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037969/
https://www.ncbi.nlm.nih.gov/pubmed/33918235
http://dx.doi.org/10.3390/cancers13071678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037969/
https://www.ncbi.nlm.nih.gov/pubmed/33918235
http://dx.doi.org/10.3390/cancers13071678

Ejemplares similares